The groundbreaking approach of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment